DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Coleman CI, Bunz TJ, Eriksson D, Meinecke AK, Sood NA.
Effectiveness and safety of rivaroxaban vs warfarin in people with non-valvular atrial fibrillation and diabetes: an administrative claims database analysis.
Diabet Med 2018;
35 (08) 1105-1110
We do not assume any responsibility for the contents of the web pages of other providers.